Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. IPH Limited
  6. Summary
    IPH   AU000000IPH9

IPH LIMITED

(IPH)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
6.75 6.77 6.72 6.74 7.03 Last
189060 537170 477824 434258 386415 Volume
+1.20% +0.30% -0.74% +0.30% +4.30% Change
Financials
Sales 2021 361 M 278 M 278 M
Net income 2021 56,0 M 43,2 M 43,2 M
Net Debt 2021 67,7 M 52,1 M 52,1 M
P/E ratio 2021 -
Yield 2021 4,00%
Sales 2022 376 M 290 M 290 M
Net income 2022 68,8 M 53,0 M 53,0 M
Net Debt 2022 45,6 M 35,1 M 35,1 M
P/E ratio 2022 18,5x
Yield 2022 4,25%
Capitalization 1 527 M 1 175 M 1 177 M
EV / Sales 2021 4,42x
EV / Sales 2022 4,18x
Nbr of Employees 900
Free-Float 97,8%
More Financials
Company
IPH Limited (IPH) is a holding company. The Company offers a range of intellectual property (IP) services and products to a client base of Fortune Global 500 companies, multinationals, public sector research organizations, small and medium-sized enterprises (SMEs) and professional services firms around the world. IPH’s IP businesses include various IP firms, including AJ Park, Griffith Hack, Shelston IP, Spruson &... 
More about the company
Ratings of IPH Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about IPH LIMITED
06/10Innate Pharma Molecule Shows Anti-Tumor Effect in Preclinical Studies
MT
02/17IPH  : Intellectual Property Services Provider IPH's Fiscal Half Statutory Net P..
MT
01/20IPH  : Morgans rates IPH as Add
AQ
2020ASTRAZENECA  : Innate Pharma To Return Immunotoxin's Commercialization Rights In..
MT
2020IPH  : Growth Plans Undaunted
AQ
2020IPH  : Morgans rates IPH as Add
AQ
2016IPH (ASX : IPH) discusses Asian expansion strategy
FI
2015IPH  : on track for solid growth
FI
More news
News in other languages on IPH LIMITED

- No features available -

More news
Chart IPH LIMITED
Duration : Period :
IPH Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IPH LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 8,17 AUD
Last Close Price 7,03 AUD
Spread / Highest target 26,6%
Spread / Average Target 16,3%
Spread / Lowest Target 7,40%
EPS Revisions
Managers and Directors
NameTitle
Andrew Nathaniel Blattman Chief Executive Officer, Executive Director & MD
John Wadley Chief Financial Officer
Richard John Grellman Independent Non-Executive Chairman
John Atkin Independent Non-Executive Director
Robin Jane Low Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
IPH LIMITED9.33%1 175
CINTAS CORPORATION-0.18%37 067
TELEPERFORMANCE SE17.51%22 650
EDENRED SE7.46%15 015
BUREAU VERITAS SA20.27%14 228
LG CORP.12.00%13 995